Clinical TrialsEmactuzumab Breaks the Cycle of Chronic Therapy in TGCT with Phase 3 Result... Emactuzumab Breaks the Cycle of Chronic Therapy in TGCT with Phase 3 Result... Read Post »
Health TidingsBioVersys and GSK’s AlpE Rewires Drug-Resistant Tuberculosis in Preclinic... BioVersys and GSK’s AlpE Rewires Drug-Resistant Tuberculosis in Preclinic... Read Post »
Clinical TrialsAllogene Brings CAR T to the Frontline Edge, ALPHA3 Shows Early MRD Win Allogene Brings CAR T to the Frontline Edge, ALPHA3 Shows Early MRD Win Read Post »
Health TidingsFDA Shines a Floodlight on Hidden Trial Data, Urges Sponsors to Report Miss... FDA Shines a Floodlight on Hidden Trial Data, Urges Sponsors to Report Miss... Read Post »
New Drug ApprovalFILSPARI Unlocks the Door for FSGS With First FDA Approval FILSPARI Unlocks the Door for FSGS With First FDA Approval Read Post »
Mergers & AcquisitionsRegeneron and Telix Set 50/50 Course for Targeted Radiopharma Expansion Regeneron and Telix Set 50/50 Course for Targeted Radiopharma Expansion Read Post »
Clinical TrialsOcular Therapeutix Shows Durable Wet AMD Control With AXPAXLI Ocular Therapeutix Shows Durable Wet AMD Control With AXPAXLI Read Post »
Health TidingsPriority Review Signals Momentum for Ifinatamab Deruxtecan in ES-SCLC Priority Review Signals Momentum for Ifinatamab Deruxtecan in ES-SCLC Read Post »
Health TidingsGenmab Advances Rina-S Combination After Clean Safety Readout Genmab Advances Rina-S Combination After Clean Safety Readout Read Post »
Health TidingsJaypirca Triple Combo Delays Relapse in Phase 3 CLL Trial Jaypirca Triple Combo Delays Relapse in Phase 3 CLL Trial Read Post »
New Drug ApprovalDupixent Extends Its Reach to Young CSU Patients in EU Dupixent Extends Its Reach to Young CSU Patients in EU Read Post »
Health TidingsRoche’s Vabysmo Breaks the Six-Month Ceiling in RVO Care Roche’s Vabysmo Breaks the Six-Month Ceiling in RVO Care Read Post »
Clinical TrialsAbbVie’s ELAHERE Combo Drives a Targeted Assault on FRα-Positive Tumors AbbVie’s ELAHERE Combo Drives a Targeted Assault on FRα-Positive Tumors Read Post »
Clinical TrialsGSK’s Mo-Rez Breaks Through in BEHOLD-1 With Strong Early Responses GSK’s Mo-Rez Breaks Through in BEHOLD-1 With Strong Early Responses Read Post »
ResearchSemaglutide Slows the Spiral of Worsening Mental Illness Semaglutide Slows the Spiral of Worsening Mental Illness Read Post »
Clinical TrialsKainova Starts Europe Dosing for DT-7012 in DOMISOL Trial Kainova Starts Europe Dosing for DT-7012 in DOMISOL Trial Read Post »
Mergers & AcquisitionsBoehringer, Click Move CT-155 to Frontline in Schizophrenia Boehringer, Click Move CT-155 to Frontline in Schizophrenia Read Post »
New Drug ApprovalMHRA Unleashes Tryngolza to Break the Triglyceride Surge in FCS MHRA Unleashes Tryngolza to Break the Triglyceride Surge in FCS Read Post »
Clinical TrialsCorcept Delivers Survival Benefit With Relacorilant in Phase 3 ROSELLA Corcept Delivers Survival Benefit With Relacorilant in Phase 3 ROSELLA Read Post »
Drugs Safety AlertOntozry Gets EMA Liver Safety Warning Ontozry Gets EMA Liver Safety Warning Read Post »
Clinical TrialsBioNTech–DualityBio ADC Delivers Across HER2 Levels in Endometrial Cancer BioNTech–DualityBio ADC Delivers Across HER2 Levels in Endometrial Cancer Read Post »
GenericsApotex Strikes First in U.S. Semaglutide Generic Push Apotex Strikes First in U.S. Semaglutide Generic Push Read Post »
Drugs Safety AlertMifepristone Lawsuits Paused as Court Waits for FDA Safety Review Mifepristone Lawsuits Paused as Court Waits for FDA Safety Review Read Post »
Mergers & AcquisitionsFrom Images to Insights: Imagene AI Partners Daiichi Sankyo From Images to Insights: Imagene AI Partners Daiichi Sankyo Read Post »
Mergers & AcquisitionsRoche, C4 Therapeutics Launch “Two-in-One” Targeted Cancer Strategy Roche, C4 Therapeutics Launch “Two-in-One” Targeted Cancer Strategy Read Post »
Clinical TrialsFDA Permits Direct Shift of Ryoncil from IND Stage to Registrational Study FDA Permits Direct Shift of Ryoncil from IND Stage to Registrational Study Read Post »
Health TidingsReplimune Hit With FDA CRL for RP1–Nivolumab in Advanced Melanoma Replimune Hit With FDA CRL for RP1–Nivolumab in Advanced Melanoma Read Post »
Health TidingsFibroBiologics Thymic Organoid (“Artificial Thymus”) Restores Immune Fu... FibroBiologics Thymic Organoid (“Artificial Thymus”) Restores Immune Fu... Read Post »
Health TidingsMacroGenics Regains Momentum as FDA Lifts Hold on LINNET Trial MacroGenics Regains Momentum as FDA Lifts Hold on LINNET Trial Read Post »
Clinical TrialsMilestone Opens Real-World Chapter for CARDAMYST With RESET-PSVT Milestone Opens Real-World Chapter for CARDAMYST With RESET-PSVT Read Post »
Clinical TrialsPREVAIL and KOMET Readouts Set Stage for Alexion at AAN 2026 PREVAIL and KOMET Readouts Set Stage for Alexion at AAN 2026 Read Post »
ManufacturingGSK Ends Wellcovorin Era as FDA Withdraws Leucovorin NDA After Discontinuat... GSK Ends Wellcovorin Era as FDA Withdraws Leucovorin NDA After Discontinuat... Read Post »
ResearchHow Novartis Is Expanding Community Health Programs Globally? How Novartis Is Expanding Community Health Programs Globally? Read Post »
Health TidingsVanda Challenges FDA Legislative Proposal on NDA Timelines and Appeals Vanda Challenges FDA Legislative Proposal on NDA Timelines and Appeals Read Post »
Clinical TrialsVanda Launches Study of NEREUS™ to Reduce Vomiting With GLP-1 Treatments Vanda Launches Study of NEREUS™ to Reduce Vomiting With GLP-1 Treatments Read Post »
Clinical TrialsNew Data Highlight Regenerative Injectables in Menopause, Weight Loss New Data Highlight Regenerative Injectables in Menopause, Weight Loss Read Post »
Mergers & AcquisitionsCosette Pharmaceuticals Acquires SYMPAZAN Portfolio from Assertio Holdings Cosette Pharmaceuticals Acquires SYMPAZAN Portfolio from Assertio Holdings Read Post »
GenericsZenyaku Kogyo to Take Sole Control of Rituxan Sales in Japan After Chugai E... Zenyaku Kogyo to Take Sole Control of Rituxan Sales in Japan After Chugai E... Read Post »
Clinical Trials Mergers & AcquisitionsBoehringer–BioNTech Partner on ES-SCLC Immunotherapy Trial Boehringer–BioNTech Partner on ES-SCLC Immunotherapy Trial Read Post »
Health TidingsEMA Update Enables Non-Cold-Chain Final Delivery for Wegovy in Europe EMA Update Enables Non-Cold-Chain Final Delivery for Wegovy in Europe Read Post »
Health TidingsLilly Expands Obesity Portfolio With Foundayo Market Launch Lilly Expands Obesity Portfolio With Foundayo Market Launch Read Post »
Generics Women & Child HealthGlenmark Expands U.S. Women’s Health Portfolio with FDA Approval of Gener... Glenmark Expands U.S. Women’s Health Portfolio with FDA Approval of Gener... Read Post »
Mergers & AcquisitionsAstellas Taps Dyno’s AI-Designed AAV Capsid to Tackle Muscle Gene Therapy... Astellas Taps Dyno’s AI-Designed AAV Capsid to Tackle Muscle Gene Therapy... Read Post »
CROFortrea Leans into AI and Automation With New FIT Clinical Technology Suite Fortrea Leans into AI and Automation With New FIT Clinical Technology Suite Read Post »
New Drug ApprovalChina Approves GSK’s Exdensur for Chronic Rhinosinusitis with Nasal Polyp... China Approves GSK’s Exdensur for Chronic Rhinosinusitis with Nasal Polyp... Read Post »
Mergers & AcquisitionsShionogi Secures Up to $482 Million BARDA Project BioShield Contract for Fe... Shionogi Secures Up to $482 Million BARDA Project BioShield Contract for Fe... Read Post »
Clinical TrialsPlus Therapeutics Wins FDA Orphan Tag for REYOBIQ Plus Therapeutics Wins FDA Orphan Tag for REYOBIQ Read Post »
Health TidingsBioengineered Liver Therapy miroliverELAP Receives FDA RMAT Designation Bioengineered Liver Therapy miroliverELAP Receives FDA RMAT Designation Read Post »
Clinical TrialsShionogi Presents Real-World CIRCE Data for Cefiderocol Shionogi Presents Real-World CIRCE Data for Cefiderocol Read Post »
